医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

AstraZeneca Chooses Box to Power Enterprise Content Collaboration for All Employees

2015年01月28日 AM12:00
このエントリーをはてなブックマークに追加


 

LOS ALTOS, Calif. & LONDON

Box today announced that AstraZeneca, a global, innovation-driven biopharmaceutical business, is making Box’s cloud content sharing and collaboration platform available to its 51,000 employees across more than 100 countries. AstraZeneca chose Box to power secure collaboration company-wide and with external parties, as well as to enable mobile access to information.

“Technology is a key driver of innovation at AstraZeneca, and collaboration and mobility are two initiatives at the forefront of our strategy,” said David Smoley, CIO at AstraZeneca. “Box has become the industry standard in this space and we’ve chosen it to continue our drive toward efficiency, security and simplicity for all our employees.”

“AstraZeneca’s move to Box follows our deep emphasis on life sciences, which is an important sector for us,” said David Quantrell, Box senior vice president and general manager of EMEA. “Box helps customers in this vertical, like AstraZeneca, confidently embrace collaboration and mobility by coupling an intuitive end-user experience with robust admin controls to securely manage information at scale.”

AstraZeneca focuses on creating environments that enable productivity through secure, user-friendly tools. Its deployment of new collaborative technology is part of the company’s larger strategy to be an innovative leader in the pharmaceutical space. AstraZeneca has also agreed to join a Box customer advisory board designed to guide new technology development and consistently improve the service to Box users.

Box makes it easy for more than 32 million individuals at 275,000 businesses around the world to share and collaborate. With today’s announcement, AstraZeneca joins a growing list of global leaders who have moved to Box, including BG Group, General Electric, Anglo American, and Schneider Electric.

About AstraZeneca

AstraZeneca is a global, innovation-driven biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of cardiovascular, metabolic, respiratory, inflammation, autoimmune, oncology, infection and neuroscience diseases. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. For more information please visit: www.astrazeneca.com.

About Box

Founded in 2005, Box (NYSE:BOX) is transforming the way people and organizations work so they can achieve their greatest ambitions. As the world’s leading enterprise software platform for content collaboration, Box helps business of all sizes in every industry securely access and manage their critical information in the cloud. Box is headquartered in Los Altos, CA, with offices across the United States, Europe and Asia. To learn more about Box, visit www.box.com.

CONTACT

Box PR
Titus Thomson, 44 (0) 2036919586
titus@box.com

同じカテゴリーの記事 

  • EMS Kegel Trainer BODYDOCTOR Opens New Era of Health Care Solutions in Global Femcare Market
  • EMSケーゲルトレーナー BODYDOCTOR、Femcareのグローバル市場でK-HEALTH CAREに注目が集まる
  • InnoCare Announces Dosing of First Patient in Clinical Study of the Combination of SHP2 Inhibitor ICP-189 and EGFR Inhibitor Furmonertinib
  • METIS第3相臨床試験で主要評価項目を達成、非小細胞肺がんからの脳転移患者における頭蓋内進行までの期間を統計学的に有意に延長
  • Poxel to Report Its 2023 Annual Results by the End of April 2024